ECTRIMS eLearning

A nurse-led research to improve the tolerability of alemtuzumab by reducing peri-infusional reactions
ECTRIMS Learn. Oriol C. 10/10/18; 231850; 107
Clara Maria Oriol
Clara Maria Oriol
Contributions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies